Chimeric antigen receptor (CAR) T cell therapy has stirred a hot debate in clinic since the first CAR T cell therapy for patients with acute lymphoblastic leukemia (ALL) got approval from FDA in August 2017. This video is going to introduce what this treatment is and how it works.
